Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life

Purpose Bladder cancer is a complex disease with a wide range of outcomes. Clinicopathological factors only partially explain the variability between patients in prognosis and treatment response. There is a need for large cohorts collecting extensive data and biological samples to: (1) investigate g...

全面介绍

书目详细资料
Main Authors: Simone Benhamou, Julia Bonastre, Bijan Ghaleh, Hélène Blanché, Pascal Eschwege, Arnauld Villers, Arnaud Méjean, François Radvanyi, Xavier Rébillard, Yves Allory, Thierry Lebret, Aldéric Fraslin, Yann Neuzillet, Stéphane Droupy, Dimitri Vordos, Laurent Guy, Marc Schneider, Patrick Coloby, Jean Lacoste, Jacques Lacoste, Jean-Luc Descotes, Guillaume Loison, Odette Mariani, Anthony Mangin, Nanor Sirab, Karine Groussard
格式: 文件
语言:English
出版: BMJ Publishing Group 2023-12-01
丛编:BMJ Open
在线阅读:https://bmjopen.bmj.com/content/13/12/e075942.full
_version_ 1827394236314550272
author Simone Benhamou
Julia Bonastre
Bijan Ghaleh
Hélène Blanché
Pascal Eschwege
Arnauld Villers
Arnaud Méjean
François Radvanyi
Xavier Rébillard
Yves Allory
Thierry Lebret
Aldéric Fraslin
Yann Neuzillet
Stéphane Droupy
Dimitri Vordos
Laurent Guy
Marc Schneider
Patrick Coloby
Jean Lacoste
Jacques Lacoste
Jean-Luc Descotes
Guillaume Loison
Odette Mariani
Anthony Mangin
Nanor Sirab
Karine Groussard
author_facet Simone Benhamou
Julia Bonastre
Bijan Ghaleh
Hélène Blanché
Pascal Eschwege
Arnauld Villers
Arnaud Méjean
François Radvanyi
Xavier Rébillard
Yves Allory
Thierry Lebret
Aldéric Fraslin
Yann Neuzillet
Stéphane Droupy
Dimitri Vordos
Laurent Guy
Marc Schneider
Patrick Coloby
Jean Lacoste
Jacques Lacoste
Jean-Luc Descotes
Guillaume Loison
Odette Mariani
Anthony Mangin
Nanor Sirab
Karine Groussard
author_sort Simone Benhamou
collection DOAJ
description Purpose Bladder cancer is a complex disease with a wide range of outcomes. Clinicopathological factors only partially explain the variability between patients in prognosis and treatment response. There is a need for large cohorts collecting extensive data and biological samples to: (1) investigate gene-environment interactions, pathological/molecular classification and biomarker discovery; and (2) describe treatment patterns, outcomes, resource use and quality of life in a real-world setting.Participants COBLAnCE (COhort to study BLAdder CancEr) is a French national prospective cohort of patients with bladder cancer recruited between 2012 and 2018 and followed for 6 years. Data on patient and tumour characteristics, treatments, outcomes and biological samples are collected at enrolment and during the follow-up.Findings to date We describe the cohort at enrolment according to baseline surgery and tumour type. In total, 1800 patients were included: 1114 patients with non-muscle-invasive bladder cancer (NMIBC) and 76 patients with muscle-invasive bladder cancer (MIBC) had transurethral resection of a bladder tumour without cystectomy, and 610 patients with NMIBC or MIBC underwent cystectomy. Most patients had a solitary lesion (56.3%) without basement membrane invasion (71.7% of Ta and/or Tis). Half of the patients with cystectomy were stage ≤T2 and 60% had non-continent diversion. Surgery included local (n=298) or super-extended lymph node dissections (n=11) and prostate removal (n=492). Among women, 16.5% underwent cystectomy and 81.4% anterior pelvectomy.Future plans COBLAnCE will be used for long-term studies of bladder cancer with focus on clinicopathological factors and molecular markers. It will lead to a much-needed improvement in the understanding of the disease. The cohort provides valuable real-world data, enabling researchers to study various research questions, assess routine medical practices and guide medical decision-making.
first_indexed 2024-03-08T18:07:37Z
format Article
id doaj.art-881caa5cd4ae4746bcdbd15266359a45
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-03-08T18:07:37Z
publishDate 2023-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-881caa5cd4ae4746bcdbd15266359a452024-01-01T14:55:08ZengBMJ Publishing GroupBMJ Open2044-60552023-12-01131210.1136/bmjopen-2023-075942Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of lifeSimone Benhamou0Julia Bonastre1Bijan Ghaleh2Hélène Blanché3Pascal Eschwege4Arnauld Villers5Arnaud Méjean6François Radvanyi7Xavier Rébillard8Yves Allory9Thierry Lebret10Aldéric Fraslin11Yann Neuzillet12Stéphane Droupy13Dimitri Vordos14Laurent Guy15Marc Schneider16Patrick Coloby17Jean Lacoste18Jacques Lacoste19Jean-Luc Descotes20Guillaume Loison21Odette Mariani22Anthony Mangin23Nanor Sirab24Karine Groussard2527INSERM U 946, Paris, France3Gustave Roussy, Service de Biostatistique et d`Epidemiologie, Villejuif, France9AP-HP, Hôpital Henri-Mondor, Plateforme de Ressources Biologiques, Créteil, France6Fondation Jean Dausset-CEPH, Paris, FranceService d`Urologie, CHU Bradois, Vandoeuvre-Lès-Nancy, France5 Department of Urology, CHU Lille, University Lille Nord de France, Lille, FranceUrology, Hopital Europeen Georges Pompidou, Paris, FranceInstitut Curie, Centre de recherche, Paris, France2Service Urologie, Clinique Beau Soleil, Montpellier, Occitanie, FranceDepartment of Pathology, Université Paris-Saclay, Institut Curie, Paris, FranceUrology, Hôpital Foch, Suresnes, FranceBiostatistics and Epidemiology, Gustave Roussy, Villejuif, FranceUrology, Hôpital Foch, Suresnes, FranceUrology, Centre Hospitalier Universitaire de Nimes, Nimes, FranceClinical Investigation Center 1430, INSERM, Créteil, FranceUrology, University Hospital Centre Gabriel Montpied, Clermont-Ferrand, FranceUrology, Hopitaux Civils de Colmar, Colmar, FranceUrology, University Hospital Center René Dubos, Cergy-Pontoise, FranceUrology, Private Hospital of Provence, Aix-en-Provence, FranceUrology, Atlantis Clinic, Saint-Herblain, FranceUrology, CHU Grenoble Alpes, Grenoble, FranceUrology, la Croix du Sud Clinic, Quint Fonsegrives, FranceBiological Resources Center, Curie Institute Hospital Group, Paris, FranceBiostatistics and Epidemiology, Gustave Roussy, Villejuif, FrancePathology, Curie Institute, Paris, FranceU1018, INSERM, Villejuif, FrancePurpose Bladder cancer is a complex disease with a wide range of outcomes. Clinicopathological factors only partially explain the variability between patients in prognosis and treatment response. There is a need for large cohorts collecting extensive data and biological samples to: (1) investigate gene-environment interactions, pathological/molecular classification and biomarker discovery; and (2) describe treatment patterns, outcomes, resource use and quality of life in a real-world setting.Participants COBLAnCE (COhort to study BLAdder CancEr) is a French national prospective cohort of patients with bladder cancer recruited between 2012 and 2018 and followed for 6 years. Data on patient and tumour characteristics, treatments, outcomes and biological samples are collected at enrolment and during the follow-up.Findings to date We describe the cohort at enrolment according to baseline surgery and tumour type. In total, 1800 patients were included: 1114 patients with non-muscle-invasive bladder cancer (NMIBC) and 76 patients with muscle-invasive bladder cancer (MIBC) had transurethral resection of a bladder tumour without cystectomy, and 610 patients with NMIBC or MIBC underwent cystectomy. Most patients had a solitary lesion (56.3%) without basement membrane invasion (71.7% of Ta and/or Tis). Half of the patients with cystectomy were stage ≤T2 and 60% had non-continent diversion. Surgery included local (n=298) or super-extended lymph node dissections (n=11) and prostate removal (n=492). Among women, 16.5% underwent cystectomy and 81.4% anterior pelvectomy.Future plans COBLAnCE will be used for long-term studies of bladder cancer with focus on clinicopathological factors and molecular markers. It will lead to a much-needed improvement in the understanding of the disease. The cohort provides valuable real-world data, enabling researchers to study various research questions, assess routine medical practices and guide medical decision-making.https://bmjopen.bmj.com/content/13/12/e075942.full
spellingShingle Simone Benhamou
Julia Bonastre
Bijan Ghaleh
Hélène Blanché
Pascal Eschwege
Arnauld Villers
Arnaud Méjean
François Radvanyi
Xavier Rébillard
Yves Allory
Thierry Lebret
Aldéric Fraslin
Yann Neuzillet
Stéphane Droupy
Dimitri Vordos
Laurent Guy
Marc Schneider
Patrick Coloby
Jean Lacoste
Jacques Lacoste
Jean-Luc Descotes
Guillaume Loison
Odette Mariani
Anthony Mangin
Nanor Sirab
Karine Groussard
Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life
BMJ Open
title Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life
title_full Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life
title_fullStr Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life
title_full_unstemmed Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life
title_short Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life
title_sort cohort profile coblance a french prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real world data on treatment patterns resource use and quality of life
url https://bmjopen.bmj.com/content/13/12/e075942.full
work_keys_str_mv AT simonebenhamou cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT juliabonastre cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT bijanghaleh cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT heleneblanche cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT pascaleschwege cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT arnauldvillers cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT arnaudmejean cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT francoisradvanyi cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT xavierrebillard cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT yvesallory cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT thierrylebret cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT aldericfraslin cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT yannneuzillet cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT stephanedroupy cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT dimitrivordos cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT laurentguy cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT marcschneider cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT patrickcoloby cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT jeanlacoste cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT jacqueslacoste cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT jeanlucdescotes cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT guillaumeloison cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT odettemariani cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT anthonymangin cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT nanorsirab cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife
AT karinegroussard cohortprofilecoblanceafrenchprospectivecohorttostudyprognosticandpredictivefactorsinbladdercancerandtogeneraterealworlddataontreatmentpatternsresourceuseandqualityoflife